Nexentis Technologies Inc. (NXTS) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-01, Nexentis Technologies Inc. (NASDAQ: NXTS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $0.63 (+0.40% 1D, market cap $1.9M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 5/20. Across 270 tracked Materials issuers, NXTS ranks #209 in composite RQD confidence.
Within the Materials sector (Agricultural Chemicals), NXTS carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -27.4%. By comparison, SNES (SenesTech Inc.) holds a D grade (45/100 RQD, P/E N/A, ROIC -35.0%, cap $5.5M) and EVGN (Evogene Ltd) posts a C- grade (59/100 RQD, P/E N/A, ROIC —, cap $6.0M). Among the 5-stock peer group, NXTS leads on earnings multiple (N/A) while AVD leads on capital efficiency (-6.1% ROIC).
Per NXTS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001789192), Nexentis Technologies Inc. generated $0 in revenue (-100.0% YoY), -$4.0M in net income, and -$3.8M in free cash flow against $20.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±12.5% realized swing band)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9
Capital intensity & 0% operating margin leave 16 pts on the table
While NXTS currently carries a cautious 42/100 (D-) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Materials with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.25) and Max Pain ($0.66) forces dealer call-delta covering toward $25.36.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Nexentis Technologies Inc. (NXTS) advanced +0.40% to $0.63, trading at 2% of its 52-week range ($0.51 – $24.15). Stretched risk/reward at current multiples (-27% return on capital) under elevated 10-year interest-rate pressure.
MitoCareX considers preliminary, not yet experimentally validated, computational findings encouraging for further computational analysis and experimental investigation Ness Ziona, Israel, Oct. 29, 2026 (GLOBE NEWSWIRE) -
Gainers Apex Critical Metals (NASDAQ:APXC) stock increased by 24.9% to $6.56 during Monday's after-market session. Paramount Gold Nevada (AMEX:PZG) shares moved upwards by 12.54% to $1.05. The company's market
MitoCareX considers preliminary, not yet experimentally validated, computational findings encouraging for further computational analysis and experimental investigation Ness Ziona, Israel, Oct. 26, 2026 (GLOBE NEWSWIRE) -
Nexentis Technologies Inc. (NASDAQ: NXTS) ("Nexentis" or the "Company") today announced that its wholly owned subsidiary, MitoCareX Bio Ltd. ("MitoCareX"), has completed an initial computational
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on NXTS today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for NXTS. Explore sector supply chains on /butterfly.
Across 270 tracked Materials securities in the Roarable RQD universe, Nexentis Technologies Inc. (NXTS) ranks #209 by composite RQD confidence (42/100, grade D-) and #270 by equity capitalization ($1.9M). Within this direct 5-issuer industry benchmark cohort, NXTS leads on earnings valuation at N/A trailing P/E, while AVD leads on capital efficiency and profitability with -6.1% ROIC and 28.6% gross margin. EVGN currently holds the highest overall quantitative score in the immediate peer group at 59/100 (C-) compared with NXTS at 42/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| NXTS
ACTIVE
Nexentis Technologies Inc. | D- | 42/100 | — | — | -27.4% | +0.40% | $1.9M | Benchmark Subject |
| SNES SenesTech Inc. | D | 45/100 | — | 62.5% | -35.0% | +4.12% | $5.5M | /snes-vs-nxts → |
| EVGN Evogene Ltd | C- | 59/100 | — | — | — | +1.60% | $6.0M | /evgn-vs-nxts → |
| FRTT Fort Technology Inc. | D+ | 56/100 | — | — | — | -3.14% | $8.1M | /frtt-vs-nxts → |
| AVD American Vanguard Corporation ($0.10 Par Value) | D- | 35/100 | — | 28.6% | -6.1% | -3.51% | $32.5M | /avd-vs-nxts → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Nexentis Technologies Inc. (NXTS) reported GAAP revenue of $0 (-100.0% vs. FY2024 revenue of $210.0K , and -100.0% cumulative change since FY2023) , GAAP net income of -$4.0M, operating cash flow of -$3.8M, and free cash flow of -$3.8M (-11.8% YoY). On the balance sheet, NXTS closed FY2025 with $20.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $0 | -$4.0M | -$3.8M | -$3.8M | $20.4M | — |
| FY2024 (FY) | 2024-12-31 | $210.0K | -$5.2M | -$3.4M | -$3.4M | $5.5M | — |
| FY2023 (FY) | 2023-12-31 | $263.0K | -$6.5M | -$3.2M | -$3.2M | — | — |
As of 2026-11-01, Nexentis Technologies Inc. (NASDAQ: NXTS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $0.63 (+0.40% 1D, market cap $1.9M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 5/20. Across 270 tracked Materials issuers, NXTS ranks #209 in composite RQD confidence.
Within the Materials sector (Agricultural Chemicals), NXTS carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -27.4%. By comparison, SNES (SenesTech Inc.) holds a D grade (45/100 RQD, P/E N/A, ROIC -35.0%, cap $5.5M) and EVGN (Evogene Ltd) posts a C- grade (59/100 RQD, P/E N/A, ROIC —, cap $6.0M). Among the 5-stock peer group, NXTS leads on earnings multiple (N/A) while AVD leads on capital efficiency (-6.1% ROIC).
Per NXTS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001789192), Nexentis Technologies Inc. generated $0 in revenue (-100.0% YoY), -$4.0M in net income, and -$3.8M in free cash flow against $20.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
NXTS last traded at $0.63 (+0.40% on volume of 1,717,021 shares), positioning the stock -49.60% below its 50-day simple moving average ($1.25) and -84.75% below its 200-day simple moving average ($4.13). Across its 52-week range of $0.51 to $24.15, NXTS sits at the 0.5% percentile with a 14-day RSI of 27.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.71).
Why NXTS Stock advanced +0.40% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-27% return on capital) under elevated 10-year interest-rate pressure.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Paper Trading Arena account.